Annual Shareholders Equity
$88.73 M
+$57.53 M+184.39%
December 31, 2023
Summary
- As of February 8, 2025, VYNE annual stockholders equity is $88.73 million, with the most recent change of +$57.53 million (+184.39%) on December 31, 2023.
- During the last 3 years, VYNE annual shareholders equity has risen by +$51.24 million (+136.67%).
- VYNE annual shareholders equity is now -31.94% below its all-time high of $130.38 million, reached on December 31, 2018.
Performance
VYNE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$63.54 M
-$11.33 M-15.14%
September 30, 2024
Summary
- As of February 8, 2025, VYNE quarterly stockholders equity is $63.54 million, with the most recent change of -$11.33 million (-15.14%) on September 30, 2024.
- Over the past year, VYNE quarterly shareholders equity has dropped by -$11.33 million (-15.14%).
- VYNE quarterly shareholders equity is now -61.66% below its all-time high of $165.70 million, reached on March 31, 2018.
Performance
VYNE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VYNE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +184.4% | -15.1% |
| 3 y3 years | +136.7% | +103.6% |
| 5 y5 years | -31.9% | +103.6% |
VYNE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +184.4% | -28.4% | +452.3% |
| 5 y | 5-year | at high | +184.4% | -31.6% | +452.3% |
| alltime | all time | -31.9% | +255.6% | -61.7% | +211.4% |
VYNE Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $63.54 M(-15.1%) |
| Jun 2024 | - | $74.87 M(-10.2%) |
| Mar 2024 | - | $83.37 M(-6.0%) |
| Dec 2023 | $88.73 M(+184.4%) | $88.73 M(+671.3%) |
| Sep 2023 | - | $11.51 M(-33.4%) |
| Jun 2023 | - | $17.27 M(-34.7%) |
| Mar 2023 | - | $26.43 M(-15.3%) |
| Dec 2022 | $31.20 M(-35.8%) | $31.20 M(-22.1%) |
| Sep 2022 | - | $40.07 M(-17.1%) |
| Jun 2022 | - | $48.36 M(-13.2%) |
| Mar 2022 | - | $55.73 M(+14.6%) |
| Dec 2021 | $48.64 M(+29.7%) | $48.64 M(-17.4%) |
| Sep 2021 | - | $58.89 M(-21.4%) |
| Jun 2021 | - | $74.89 M(-19.4%) |
| Mar 2021 | - | $92.90 M(+147.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $37.49 M(-45.3%) | $37.49 M(-24.3%) |
| Sep 2020 | - | $49.52 M(-30.8%) |
| Jun 2020 | - | $71.53 M(+2.9%) |
| Mar 2020 | - | $69.53 M(+1.5%) |
| Dec 2019 | $68.51 M(-47.5%) | $68.51 M(-21.3%) |
| Sep 2019 | - | $87.00 M(-14.9%) |
| Jun 2019 | - | $102.18 M(-11.6%) |
| Mar 2019 | - | $115.63 M(-11.3%) |
| Dec 2018 | $130.38 M(-328.6%) | $130.38 M(-11.2%) |
| Sep 2018 | - | $146.88 M(-7.1%) |
| Jun 2018 | - | $158.19 M(-4.5%) |
| Mar 2018 | - | $165.70 M(-390.5%) |
| Dec 2017 | -$57.03 M(+93.7%) | -$57.03 M(+18.9%) |
| Sep 2017 | - | -$47.96 M(+62.9%) |
| Dec 2016 | -$29.44 M(+84.5%) | -$29.44 M |
| Dec 2015 | -$15.95 M | - |
FAQ
- What is VYNE Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for VYNE Therapeutics?
- What is VYNE Therapeutics annual shareholders equity year-on-year change?
- What is VYNE Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly shareholders equity year-on-year change?
What is VYNE Therapeutics annual stockholders equity?
The current annual shareholders equity of VYNE is $88.73 M
What is the all time high annual shareholders equity for VYNE Therapeutics?
VYNE Therapeutics all-time high annual stockholders equity is $130.38 M
What is VYNE Therapeutics annual shareholders equity year-on-year change?
Over the past year, VYNE annual stockholders equity has changed by +$57.53 M (+184.39%)
What is VYNE Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VYNE is $63.54 M
What is the all time high quarterly shareholders equity for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly stockholders equity is $165.70 M
What is VYNE Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VYNE quarterly stockholders equity has changed by -$11.33 M (-15.14%)